Strategies to prevent type 2 diabetes

被引:34
作者
Abuissa, H
Bell, DSH
O'Keefe, JH
机构
[1] Cardiovasc Consultants, Mid Amer Heart Inst, Kansas City, MO 64111 USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
关键词
ACE inhibitors; ARBs; carvedilol; diabetes; metabolic syndrome; prevention;
D O I
10.1185/030079905X50606
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus is a public health problem of epidemic proportions and its prevalence is on the rise. The typical American born today has a one in three chance of developing type 2 diabetes. This diagnosis is associated with an adverse cardiovascular prognosis and is considered the risk equivalent of established coronary disease. Many risk factors, including the metabolic syndrome, have been implicated in its development. Even in high-risk individuals, type 2 diabetes is a preventable disease. Diet and exercise have been consistently shown to decrease the incidence of diabetes in large randomized controlled studies. Additionally, new-onset diabetes was reduced by several oral pharmacologic anti-diabetic agents including metformin, acarbose and troglitazone in randomized trials which studied patients with impaired glucose tolerance. More interestingly, multiple large prospective studies have also reported a reduction in the development of type 2 diabetes in patients treated with antihypertensive agents, predominantly angiotensin converting enzyme inhibitors and angiotensin receptor blockers. In this review, we will discuss some of these important trials and the speculative mechanisms whereby those medications prevent type 2 diabetes. Such observations, if proven to be true, may represent preventive strategies which can be considered in patients with pre-diabetic conditions such as the metabolic syndrome, hypertension, impaired fasting glucose, family history of diabetes, obesity, congestive heart failure or other risks for the development of type 2 diabetes.
引用
收藏
页码:1107 / 1114
页数:8
相关论文
共 69 条
  • [11] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
    Chiasson, JL
    Josse, RG
    Gomis, R
    Hanefeld, M
    Karasik, A
    Laakso, M
    [J]. LANCET, 2002, 359 (9323) : 2072 - 2077
  • [12] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [13] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    [J]. LANCET, 2002, 359 (9311) : 995 - 1003
  • [14] Hyperinsulinemia as an independent risk factor for ischemic heart disease
    Despres, JP
    Lamarche, B
    Mauriege, P
    Cantin, B
    Dagenais, GR
    Moorjani, S
    Lupien, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) : 952 - 957
  • [15] Diabetes Prevention Progam, 2005, DIABETES, V54, P1150
  • [16] High-intensity resistance training improves glycemic control in older patients with type 2 diabetes
    Dunstan, DW
    Daly, RM
    Owen, N
    Jolley, D
    De Courten, M
    Shaw, J
    Zimmet, P
    [J]. DIABETES CARE, 2002, 25 (10) : 1729 - 1736
  • [17] Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome - A randomized trial
    Esposito, K
    Marfella, R
    Ciotola, M
    Di Palo, C
    Giugliano, F
    Giugliano, G
    D'Armiento, M
    D'Andrea, F
    Giugliano, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (12): : 1440 - 1446
  • [18] Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
    Ford, ES
    Giles, WH
    Dietz, WH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03): : 356 - 359
  • [19] TISSUE-SPECIFIC NUTRITIONAL REGULATION OF ANGIOTENSINOGEN IN ADIPOSE-TISSUE
    FREDERICH, RC
    KAHN, BB
    PEACH, MJ
    FLIER, JS
    [J]. HYPERTENSION, 1992, 19 (04) : 339 - 344
  • [20] Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase
    Fryer, LGD
    Hajduch, E
    Rencurel, F
    Salt, IP
    Hundal, HS
    Hardie, DG
    Carling, D
    [J]. DIABETES, 2000, 49 (12) : 1978 - 1985